Developer of bio-signal processing and biologically inspired robotics. It offers MELTz, a hand motion rehabilitation system that uses muscle electrical data to provide training tailored to the patient's movement intentions, supporting neurorehabilitation through the integration of advanced technologies. It also, offer MELTANT, a dexterous 5-finger robot hand capable of performing non-standardized tasks. Founded in 2013, headquartered in Tokyo, Japan. The company has raised $20.1M in funding at t The company operates in Life Sciences > Orthopedics, HealthTech > Assistive Tech, High Tech > Consumer Robotics. Its business models include Consumer Robotics > Healthcare > Robotic Assistance > Prosthetics, Assistive Tech > Assistive Hardware > Mobility > Prostheses, Orthopedics > Medical Devices > Therapies > Rehabilitation > Prostheti. Founded in 2013. Headquartered in Japan, Tokyo. The company has raised funding at the Series B stage. Backed by investors including Globalink, Realtech Fund, Japan Medical Device Development Organization, Mirai Creation Fund, Sumitomo Dainippon Pharma, Dai-Ichi Life, SBI Investment, Glocalink, HILL HOUSE.
MELTIN MMI
Series BDeveloper of bio-signal processing and biologically inspired robotics. It offers MELTz, a hand motion rehabilitation system that uses muscle electrical data to provide training tailored to the patient's movement intentions, supporting neurorehabilitation through the integration of advanced technologies. It also, offer MELTANT, a dexterous 5-finger robot hand capable of performing non-standardized tasks. Founded in…
About
Business model
Consumer Robotics > Healthcare > Robotic Assistance > Prosthetics,
Assistive Tech > Assistive Hardware > Mobility > Prostheses,
Orthopedics > Medical Devices > Therapies > Rehabilitation > Prosthetics > Brain Interface Device
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.